DE10399004I1 - Klonierung und Expression von Wirtsschuetzenden immunogenen des Infektioesen Bursavirus (ibdv) - Google Patents

Klonierung und Expression von Wirtsschuetzenden immunogenen des Infektioesen Bursavirus (ibdv)

Info

Publication number
DE10399004I1
DE10399004I1 DE2003199004 DE10399004C DE10399004I1 DE 10399004 I1 DE10399004 I1 DE 10399004I1 DE 2003199004 DE2003199004 DE 2003199004 DE 10399004 C DE10399004 C DE 10399004C DE 10399004 I1 DE10399004 I1 DE 10399004I1
Authority
DE
Germany
Prior art keywords
bursavirus
ibdv
immunogenic
cloning
infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE2003199004
Other languages
English (en)
Other versions
DE10399004I2 (de
Inventor
Ahmed Azad
Peter Hudson
Kevin Fahey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commonwealth Scientific and Industrial Research Organization CSIRO
Original Assignee
Commonwealth Scientific and Industrial Research Organization CSIRO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commonwealth Scientific and Industrial Research Organization CSIRO filed Critical Commonwealth Scientific and Industrial Research Organization CSIRO
Application granted granted Critical
Publication of DE10399004I1 publication Critical patent/DE10399004I1/de
Publication of DE10399004I2 publication Critical patent/DE10399004I2/de
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE2003199004 1985-05-30 1986-05-30 Klonierung und expression von Wirtssch}tzenden immunogenen des Infektioesen Bursavirus (ibdv). Active DE10399004I2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPH081585 1985-05-30
AUPH211885 1985-08-23
PCT/AU1986/000156 WO1986007060A1 (en) 1985-05-30 1986-05-30 Cloning and expression of host-protective immunogens of ibdv

Publications (2)

Publication Number Publication Date
DE10399004I1 true DE10399004I1 (de) 2003-06-05
DE10399004I2 DE10399004I2 (de) 2005-09-08

Family

ID=25642952

Family Applications (2)

Application Number Title Priority Date Filing Date
DE2003199004 Active DE10399004I2 (de) 1985-05-30 1986-05-30 Klonierung und expression von Wirtssch}tzenden immunogenen des Infektioesen Bursavirus (ibdv).
DE3650319T Expired - Lifetime DE3650319T2 (de) 1985-05-30 1986-05-30 Klonierung und expression von wirtsschützenden immunogenen des infektioesen bursavirus (ibdv).

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE3650319T Expired - Lifetime DE3650319T2 (de) 1985-05-30 1986-05-30 Klonierung und expression von wirtsschützenden immunogenen des infektioesen bursavirus (ibdv).

Country Status (7)

Country Link
US (2) US6054126A (de)
EP (1) EP0222842B1 (de)
JP (1) JP2988622B2 (de)
CA (1) CA1334941C (de)
DE (2) DE10399004I2 (de)
NL (1) NL300114I2 (de)
WO (1) WO1986007060A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5254463A (en) * 1981-09-18 1993-10-19 Genentech, Inc. Method for expression of bovine growth hormone
US5489529A (en) * 1984-07-19 1996-02-06 De Boer; Herman A. DNA for expression of bovine growth hormone
JPH03500601A (ja) * 1987-06-26 1991-02-14 コモンウェルス　サイエンティフィック　アンド　インダストリアル　リサーチ　オーガナイゼイション ウィルス中和及び保護モノクローナル抗体により認識されるｉｂｄｖ　ｖｐ２エピトープ
US5614409A (en) * 1989-05-30 1997-03-25 Commonwealth Scientific And Industrial Research Organisation Production of IBDV VP2 in highly immunogenic form
US5632989A (en) * 1989-10-18 1997-05-27 University Of Maryland Attenuated, live vaccine for Delaware strain IBDV
EP0481072A4 (en) * 1990-05-04 1993-06-09 University Of Maryland At College Park Specific dna sequences related to an ibdv protein including vectors, hosts and vaccines
US6165793A (en) * 1996-03-25 2000-12-26 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US5871744A (en) * 1996-09-05 1999-02-16 University Of Maryland-Biotechnology Inst. Method for generating birnavirus from synthetic RNA transcripts
US6231868B1 (en) 1997-09-30 2001-05-15 University Of Maryland-Biotechnology Institute Method for generating nonpathogenic infections birnavirus from synthetic RNA transcripts
WO2000012677A2 (en) * 1998-09-01 2000-03-09 The University Of Hong Kong Generation of recombinant infectious bursal disease viruses by reverse genetics technology and the use of the recombinant viruses as attenuated vaccines
AU2000252449A1 (en) * 2000-06-19 2002-01-02 Rahan Meristem Recombinant vaccines against infectious bursal disease virus
FR2824327B1 (fr) * 2001-05-02 2003-07-11 Agronomique Inst Nat Rech Particules pseudovirales de birnavirus
US6764684B2 (en) 2001-09-28 2004-07-20 Zeon Corporation Avian herpesvirus-based recombinant infectious bursal disease vaccine
US20040146530A1 (en) * 2002-01-30 2004-07-29 Sharma Jagdev M Avian vaccine effective against infectious bursal disease virus
WO2005049794A2 (en) 2003-11-13 2005-06-02 University Of Georgia Research Foundation, Inc. Methods of characterizing infectious bursal disease virus

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4237224A (en) * 1974-11-04 1980-12-02 Board Of Trustees Of The Leland Stanford Jr. University Process for producing biologically functional molecular chimeras
US4356270A (en) * 1977-11-08 1982-10-26 Genentech, Inc. Recombinant DNA cloning vehicle
WO1985002545A1 (en) * 1983-12-13 1985-06-20 Commonwealth Scientific And Industrial Research Or Infectious bursal disease virus vaccine
JPH03500601A (ja) * 1987-06-26 1991-02-14 コモンウェルス　サイエンティフィック　アンド　インダストリアル　リサーチ　オーガナイゼイション ウィルス中和及び保護モノクローナル抗体により認識されるｉｂｄｖ　ｖｐ２エピトープ
US5614409A (en) * 1989-05-30 1997-03-25 Commonwealth Scientific And Industrial Research Organisation Production of IBDV VP2 in highly immunogenic form

Also Published As

Publication number Publication date
EP0222842B1 (de) 1995-05-10
NL300114I2 (nl) 2003-10-01
JP2988622B2 (ja) 1999-12-13
EP0222842A1 (de) 1987-05-27
DE3650319T2 (de) 1996-01-25
US6054126A (en) 2000-04-25
US5849575A (en) 1998-12-15
EP0222842A4 (de) 1988-10-05
DE10399004I2 (de) 2005-09-08
DE3650319D1 (de) 1995-06-14
WO1986007060A1 (en) 1986-12-04
CA1334941C (en) 1995-03-28
NL300114I1 (nl) 2003-04-01
JPH09316094A (ja) 1997-12-09

Similar Documents

Publication Publication Date Title
DE10399004I1 (de) Klonierung und Expression von Wirtsschuetzenden immunogenen des Infektioesen Bursavirus (ibdv)
DE3689427T2 (de) Klonierung von Restriktions- und Modifikationsgenen.
DE68910713T2 (de) Isolierung, Reinigung, Charakterisierung, Klonierung und Sequenzierung von N-alpha-Acetyltransferase.
DE3783573T2 (de) Komplex von pullulan und polyaethylenglykol.
DE3674389D1 (de) Wiedergewinnung von kuehlmitteln und reinigungssystem.
DE10075008I1 (de) Analoga von Insulin und deren Herstellungsmethode
DE3669997D1 (de) Rollstuhl und anwendungsweise.
DE3485267D1 (de) Herstellung von streptokokken-m-protein-immunogenen und molekularen sonden.
NO165398C (no) Analogifremgangsmaate og fremstilling av terapeutisk aktive nitrofuranderivater.
DE3677382D1 (de) Copolymere von difluormethylenoxid und tetrafluoraethylenoxid.
KR880700673A (ko) 골손상 치료용방법 및 조성물
DE3751576T2 (de) Virale Inaktivierung und Reinigung von aktiven Proteinen.
BR8606969A (pt) Perfluoropolieteres e processo de preparacao dos mesmos e de oxido de perfluoropolimetileno
DE3688937T2 (de) Herstellung optisch aktiver aryloxypropanolamine und arylaethanolamine.
KR880701524A (ko) 1-옥소히드로카르빌-치환 아자시클로헥산으로 되는 조성물 및 그의 용도
ZA872997B (en) Novel styryl pyrazoles,isoxazoles and analogs thereof having activity as 5-lipoxygenase inhibitors,pharmaceutical compositions and methods of use therefor
KR930702527A (ko) gp160의 유도체 및 보조약을 함유하는 gp160 또는 그의 유도체를 기재로하는 백신
DE3583858D1 (de) Derivate von alcoxymethylaether und alcoxymethylester.
ATE78984T1 (de) Rueckgewinnung und uebertragung von aroma.
TR24945A (tr) IMIDOZAL TüREVLERI BU TüREVLERIN HAZIRLANISI VE FUNGISIT OLARAK KULLANILMALARI
DE3675063D1 (de) Mischungen von polycaprolactonpolyolen und polyepoxyden.
DK133287D0 (da) Vaccine, fremgangsmaader ved dens fremstilling samt vaccineudstyr
FI863387A (fi) Anordning foer sammanfogning och faestning av rektangulaera skivor.
ATE103977T1 (de) Klonierung und expression des sauren fibroblastenwachstumsfaktors.
KR870006432U (ko) 회전식 목침겸 발받이

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Free format text: PATENTANWAELTE REICHEL UND REICHEL, 60322 FRANKFURT